Sitacure 100 helps manage blood sugar levels in patients with Type 2 diabetes by enhancing the body’s ability to regulate glucose. The active ingredient in Sitacure 100, sitagliptin, is a DPP-4 inhibitor. DPP-4 inhibitors work by increasing the levels of incretin hormones, which stimulate insulin release in response to food. This increased insulin helps lower blood sugar levels after meals, preventing spikes in glucose levels.

In addition to boosting insulin production, Sitacure 100 reduces the amount of glucose produced by the liver when it’s not needed. Normally, the liver releases glucose to maintain energy between meals, but in Type 2 diabetes, this process can become unregulated. Sitacure 100 helps to control this overproduction, leading to a more balanced blood sugar level throughout the day.

By improving insulin sensitivity and lowering glucose production, Sitacure 100 offers a two-pronged approach to blood sugar management. This dual action makes it effective in controlling both fasting and post-meal glucose levels. When combined with a healthy diet and regular exercise, Sitacure 100 provides significant support for patients seeking to maintain optimal blood sugar control.